The leadership team at Spero Therapeutics has a history of experience in the medical and pharmaceutical industries. They have been advisors at Judo Therapeutics and Journey Colab, and have also co-founded and been on the board of directors for Synlogic, Inc. and Rodin Therapeutics. Most recently, they have been working as the Vice President of Program Management at Cubist Pharmaceuticals. They also have experience in preclinical work, clinical work, and marketing from their time at Wyeth.
Ankit Mahadevia
Chairman
Cristina Larkin
Chief Operating Officer
David Musselman
SVP, Sales & Market Access
Frank E. Thomas
Director
Jay Blackington
VP, People Strategy & Culture
Jennifer Reese
VP, Medical Affairs
John C. Pottage
Director
Melissa Stundick
VP, Business Development
Michael Pucci
Executive Director, Early Drug...
Scott Jackson
Director
Terese Hoekstra
VP, Market Access
Thomas Parr
Chief Scientific Officer
Timothy Keutzer
Chief Development Officer
Tregoning Prior
Director
Troy Lister
VP, R&D
View all